1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Exicure, Inc.
  6. News
  7. Summary
    XCUR   US30205M1018

EXICURE, INC.

(XCUR)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe BZX - 05/25 11:51:02 am
0.117 USD   +0.09%
05/20Top Premarket Gainers
MT
05/19INSIDER BUY : Exicure
MT
05/17Exicure, Inc. - Reports First Quarter 2022 Financial Results and Corporate Progress
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about EXICURE, INC.
05/19INSIDER BUY : Exicure
MT
05/17Exicure, Inc. - Reports First Quarter 2022 Financial Results and Corporate Progress
AQ
05/17Exicure Announces Presentation at 2022 H.C. Wainwright Global Life Sciences Conference
BU
05/16Exicure, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/16Earnings Flash (XCUR) EXICURE Reports Q1 Revenue $2.57M
MT
05/16Exicure, Inc. Reports First Quarter 2022 Financial Results and Corporate Progress
BU
05/11Thinking about buying stock in Exicure, Vroom, Redbox, Amyris, or Plug Power?
PR
05/11Exicure to Sell $5 Million of Common Stock in Private Placement at Premium
MT
05/10Exicure Announces $5 Million Raise in Private Placement Transaction Priced at Market Pr..
BU
05/09Exicure to Present at Upcoming TIDES USA Oligonucleotide & Peptide Therapeutics Confere..
BU
05/09Exicure, Inc. announced that it expects to receive $5.040289 million in funding from Ab..
CI
03/29Chardan Adjusts Exicure's Price Target to $0.25 From $0.40 'on Increased Dilution;' Neu..
MT
03/28Exicure, Inc. Reports Full Year 2021 Financial Results and Corporate Progress
AQ
03/25EXICURE : Reports Full Year 2021 Financial Results and Corporate Progress - Form 8-K
PU
03/25Exicure Loss Widens Last Year, Sees Enough Funds Through Q4
MT
More most relevant news
All news about EXICURE, INC.
05/20Top Premarket Gainers
MT
05/19INSIDER BUY : Exicure
MT
05/17Exicure, Inc. - Reports First Quarter 2022 Financial Results and Corporate Progress
AQ
05/17Exicure Announces Presentation at 2022 H.C. Wainwright Global Life Sciences Conference
BU
05/16EXICURE, INC. Management's Discussion and Analysis of Financial Condition and Results ..
AQ
05/16Exicure, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/16Earnings Flash (XCUR) EXICURE Reports Q1 Revenue $2.57M
MT
05/16Exicure, Inc. Reports First Quarter 2022 Financial Results and Corporate Progress
BU
05/13EXICURE, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Se..
AQ
05/11Thinking about buying stock in Exicure, Vroom, Redbox, Amyris, or Plug Power?
PR
More news
News in other languages on EXICURE, INC.
05/19ACHAT D'INITIÉS : Exicure
05/16Exicure, Inc. annonce ses résultats pour le premier trimestre se terminant le 31 mars 2..
05/16Earnings Flash (XCUR) EXICURE annonce un chiffre d'affaires de 2,57 millions de dollars..
05/11MISE À JOUR SECTORIELLE : Les actions du secteur de la santé sont en baisse avant la cloch..
03/25La perte d'Exicure s'est creusée l'année dernière, mais elle dispose de suffisamment de..
03/25Exicure, Inc. annonce ses résultats pour l'année complète se terminant le 31 décembre 2..
03/25Exicure, Inc. Le vérificateur remet en question la continuité de l'exploitation.
02/04Le président-directeur général, le président du conseil d'administration et d'autres me..
02/04Exicure, Inc. annonce un changement de chef de la direction, à compter du 4 février 202..
02/04Exicure, Inc. annonce des changements au niveau de la direction, du conseil d'administr..
More news
Analyst Recommendations on EXICURE, INC.
03/29Chardan Adjusts Exicure's Price Target to $0.25 From $0.40 'on Increased Dilution;' Neu..
MT
2021Chardan Downgrades Exicure to Neutral From Buy After Probe Shows Clinical Data Misrepre..
MT
2021Chardan Adjusts Price Target on Exicure to $2.25 From $7 'on Uncertain Delays for Clini..
MT
2021EXICURE : HC Wainwright Adjusts Price Target on Exicure to $6 From $8, Maintains Buy Ratin..
MT
2020EXICURE : BMO Capital Starts Exicure at Outperform With $6 Price Target
MT
More recommendations
Press releases
05/17Exicure, Inc. - Reports First Quarter 2022 Financial Results and Corporate Progress
AQ
05/17Exicure Announces Presentation at 2022 H.C. Wainwright Global Life Sciences Conference
BU
05/16EXICURE, INC. Management's Discussion and Analysis of Financial Condition and Results ..
AQ
05/16Exicure, Inc. Reports First Quarter 2022 Financial Results and Corporate Progress
BU
05/13EXICURE, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Se..
AQ
More press releases